A tool that makes virus tracking and vaccine production simpler and more efficient can dramatically accelerate the creation of life-saving products, such as the development and production of vaccines, to prevent sickness and death worldwide. The Virus Counter by ViroCyt is such a system. Bob Kline ’79 is the president and CEO of ViroCyt.
“The ability to easily and quickly follow the impact of a given therapy on viral concentration provides significant advantages over traditional approaches that slow down the pace of research by days or weeks,” says Kline.
ViroCyt has used its Virus Counter in partnership with the United States Army Medical Research Institute of Infectious Diseases to accelerate Ebola research.